BSE Live
Jan 20, 16:01Prev. Close
1548.35
Open Price
1545.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 20, 15:58Prev. Close
1549.50
Open Price
1549.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1535.80 (196)
| Cash Flow of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 219.33 | 201.35 | 108.14 | 135.57 | |
| Net CashFlow From Operating Activities | 280.97 | 287.87 | 52.89 | 217.21 | |
| Net Cash Used In Investing Activities | -119.53 | -213.05 | -142.63 | -134.65 | |
| Net Cash Used From Financing Activities | -193.37 | -23.25 | 81.20 | -74.11 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -31.93 | 51.57 | -8.54 | 8.45 | |
| Cash And Cash Equivalents Begin of Year | 60.68 | 7.48 | 16.91 | 8.47 | |
| Cash And Cash Equivalents End Of Year | 28.75 | 59.05 | 8.37 | 16.91 |
09.01.2026
07.01.2026
24.12.2025
10.12.2025
17.11.2025
Emcure Pharmace Consolidated September 2025 Net Sales at Rs 2,269.82 crore, up 13.38% Y-o-Y
12.11.2025
Emcure Pharmace Standalone September 2025 Net Sales at Rs 1,260.60 crore, up 14.12% Y-o-Y
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y